Drugs / AIDSVAX B/B
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00002441 | — | HIV infectious disease | VaxGen | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AIDSVAX B/B | “The purpose of this study is to see if an HIV vaccine, AIDSVAX B/B, can protect adults who are at risk from becoming infected with HIV.” NCT00002441 ↗ |
| Modality | Vaccine | “The purpose of this study is to see if an HIV vaccine, AIDSVAX B/B, can protect adults who are at risk from becoming infected with HIV.” NCT00002441 ↗ |
| Route | Intramuscular | “Volunteers receive 7 blinded, intramuscular vaccinations” NCT00002441 ↗ |